Alternative approaches to transplanting HCV-positive organs

• Maintain the current exclusion of HCV-positive organs for organ transplantation.
• Allow unrestricted use of HCV-positive organs and tissue for transplantation, use being based primarily on the informed choices of patients.
• Allow the use of HCV-positive organs for transplantation where the transplant is life-saving and no alternative exists (heart, lung, liver), for patients who have been on a waiting list for an unacceptable time, or for whom alternative medical treatment is unsatisfactory, while maintaining current restrictions on "elective" renal and pancreatic transplantation from HCV-positive donors.
• Allow the transplantation of organs from anti-HCV-positive donors into patients already positive for anti-HCV or HCV RNA (perhaps after HCV genotype matching).
• Deregulate transplant coordination, allowing each transplant unit to consider the relevant medical and ethical issues and determine their own policies for the use of HCV-positive organs.